- Home
- XNCR vs NAC Comparison
XNCR vs NAC Comparison
Compare XNCR & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- NAC
- Stock Information
- Founded
- XNCR 1997
- NAC 1998
- Country
- XNCR United States
- NAC France
- Employees
- XNCR N/A
- NAC N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- NAC Investment Managers
- Sector
- XNCR Health Care
- NAC Finance
- Exchange
- XNCR Nasdaq
- NAC Nasdaq
- Market Cap
- XNCR 1.7B
- NAC 1.6B
- IPO Year
- XNCR 2013
- NAC N/A
- Fundamental
- Price
- XNCR $20.45
- NAC $11.22
- Analyst Decision
- XNCR Strong Buy
- NAC
- Analyst Count
- XNCR 9
- NAC 0
- Target Price
- XNCR $36.33
- NAC N/A
- AVG Volume (30 Days)
- XNCR 766.2K
- NAC 307.3K
- Earning Date
- XNCR 02-25-2025
- NAC 01-01-0001
- Dividend Yield
- XNCR N/A
- NAC 4.33%
- EPS Growth
- XNCR N/A
- NAC N/A
- EPS
- XNCR N/A
- NAC N/A
- Revenue
- XNCR $85,164,000.00
- NAC N/A
- Revenue This Year
- XNCR N/A
- NAC N/A
- Revenue Next Year
- XNCR $80.86
- NAC N/A
- P/E Ratio
- XNCR N/A
- NAC N/A
- Revenue Growth
- XNCR N/A
- NAC N/A
- 52 Week Low
- XNCR $15.31
- NAC $9.32
- 52 Week High
- XNCR $27.24
- NAC $11.21
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- NAC 43.31
- Support Level
- XNCR $19.15
- NAC $11.15
- Resistance Level
- XNCR $24.66
- NAC $11.24
- Average True Range (ATR)
- XNCR 1.14
- NAC 0.09
- MACD
- XNCR -0.37
- NAC 0.00
- Stochastic Oscillator
- XNCR 24.96
- NAC 28.44
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.